Advancedpopulation

Linkage Analysis

Overview

Linkage analysis maps disease genes by tracking marker-disease co-segregation in families: markers near the disease gene travel together (few recombinants). The LOD score (log10 of odds favoring linkage) quantifies evidence: LOD >= 3 (1000:1) declares linkage. This mapped Huntington's (1983, chromosome 4), CFTR, and BRCA1 before the genome era; GWAS and sequencing have largely superseded it for complex traits.

Learning objectives

  • Explain co-segregation logic
  • Interpret LOD scores
  • Describe how Huntington's was mapped
  • Compare linkage vs association

The logic

In a family, a DNA marker physically near the disease gene recombines rarely with it: affected relatives share the same marker allele (identical by descent). Count recombinants vs non-recombinants across meioses: few recombinants -> linked. Recombination fraction theta estimates distance.

Co-segregation = proximity

Markers and genes traveling together through pedigrees must be neighbors.

LOD scores

LOD = log10(likelihood of data if linked at theta / if unlinked). LOD 3 = 1000:1 odds -> significant (Morton, 1955). LOD -2 excludes linkage. Multipoint analysis uses many markers simultaneously; affected-sib-pair methods work without knowing the mode of inheritance.

LOD 3: the 1000:1 rule

The traditional threshold balancing false positives across the genome.

Triumphs

Huntington's (1983): first disease gene mapped by linkage (Gusella, chromosome 4p), a decade before the gene was found. CFTR (1989), BRCA1 (1994), and hundreds of Mendelian genes fell to linkage + positional cloning. It owned the 1985-2005 gene-mapping era.

Mendelian success, complex failure

Linkage excelled at single-gene disorders but lacked power for small-effect polygenes.

Linkage vs association

Linkage: families, rare variants, large effects, coarse resolution (megabases). Association (GWAS): populations, common variants, small effects, fine resolution. Sequencing now finds Mendelian genes directly; linkage remains useful for mapping in large pedigrees and validating.

Complementary eras

Linkage found the big-effect genes; GWAS found the small-effect multitudes.

Key points

  • Markers co-segregating with disease across meioses indicate linkage
  • LOD >= 3 declares linkage (1000:1 odds)
  • Mapped Huntington's (1983), CFTR, BRCA1 pre-genome
  • Linkage: families/rare/large-effect; GWAS: populations/common/small-effect

Common misconceptions

✗ Myth: LOD 3 means 3% significance.

✓ Truth: LOD is log10 odds: 3 = 1000:1 odds favoring linkage, roughly p ~ 10^-4.

✗ Myth: Linkage identifies the exact mutation.

✓ Truth: It maps to megabase regions; positional cloning/sequencing then finds the gene.

Practice questions

Q1. A LOD score of 3 means
  1. p = 0.03
  2. 1000:1 odds in favor of linkage
  3. 3% recombination
  4. 3 genes
Answer: B.

log10(1000) = 3: the traditional significance threshold.

Q2. Linkage analysis tracks ___ in families
  1. Mutations directly
  2. Marker-disease co-segregation
  3. Proteins
  4. Fossils
Answer: B.

Shared marker alleles among affecteds imply a nearby disease gene.

Q3. Huntington's disease was mapped to chromosome 4 in
  1. 1953
  2. 1983
  3. 2003
  4. 2023
Answer: B.

Gusella's landmark: the first disease gene mapped by linkage.

Click a question to reveal the answer and explanation.

Frequently asked questions

Why did Huntington's mapping matter?

First autosomal disease gene mapped (1983), enabling predictive testing a decade before gene identification.

What is multipoint linkage?

Using multiple markers simultaneously to extract maximal inheritance information across a region.

Why did linkage fail for diabetes?

Complex traits involve many small-effect variants: linkage lacks power where GWAS (barely) succeeds.